Trials / Recruiting
RecruitingNCT06429436
Vending Machine Naloxone Distribution for Your Community (VENDY)
Vending Machine Naloxone Distribution for Your Community (VENDY): Increasing Reach and Implementation of Naloxone Distribution
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 4,000 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.
Detailed description
This pilot assessment of the VENDY program will take place in 3 communities. Each community will have a machine (vending or kiosks) in which naloxone will be distributed for free to community members. Our preliminary work identified the locations desired by community members who use illegal drugs for machine placement. The pilot test test will include evaluation of the reach (naloxone distribution), adoption (% of sites and staff implementing), and implementation (fidelity to restocking and maintenance protocol) of VENDY in each community.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | VENDY | At least 1 machine (vending machine like a snack machine or a machine like a newspaper kiosk) will be placed in the respective community served by the participating organizations. Any person in the community can get naloxone from the machine. The vending machine will require a code that will be placed on the machine for anyone to use. The kiosks are a box that you simply pull open and naloxone can be obtained. Naloxone kits will be provided for free as part of the current naloxone distribution program within each respective organization. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2026-01-01
- Completion
- 2026-06-30
- First posted
- 2024-05-28
- Last updated
- 2025-11-13
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06429436. Inclusion in this directory is not an endorsement.